Peripheral hypertrophic subepithelial corneal opacification – Role of tear secretion, medication and systemic diseases

Jana C. Riedl,Aminat Misirkhanova,Joanna Wasielica‐Poslednik,Alexander K. Schuster,Irene Schmidtmann,Manfred E. Beutel,Norbert Pfeiffer,Adrian Gericke,Alexander K. Schuster
DOI: https://doi.org/10.1111/aos.16680
2024-03-28
Acta Ophthalmologica
Abstract:Background Peripheral hypertrophic subepithelial corneal opacification (PHSCO) is a corneal disease that may severely affect vision. The major goal of this study was to test the hypothesis that tear secretion, medication and systemic diseases are associated with PHSCO. Methods This is a retrospective, case–control study conducted at the Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University Mainz. We analysed medical records of patients diagnosed with PHSCO. Sex, age, Schirmer's test II, general medication and medical history were assessed and compared to an age‐ and sex‐matched control group from the Gutenberg Health Study (GHS). Results One hundred ninety‐five eyes of 112 patients with PHSCO were included. Eighty‐eight patients were female with a mean age of 55.3 ± 14.7 years (23–89 years) and 24 patients were male with a mean age of 59.3 ± 12.6 years (38–84 years). In 83 patients (74.1%) both eyes were involved. The Schirmer's test II was significantly reduced in patients with PHSCO compared to the GHS control group (p
ophthalmology
What problem does this paper attempt to address?